← Open Payments lookup

KATELYN CONNER: Open Payments

NPI 1760902712 · SOUTHAVEN, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,996 in 128 payments from 16 companies in 2025. Trend: 2023 $1,944 · 2024 $1,748 · 2025 $1,996

Food & beverage: $1,969Education: $27
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)20$439
ABBVIE INC.24$277
Collegium Pharmaceutical, Inc.19$228
Neurocrine BioSciences, Inc.14$211
Alkermes, Inc.11$155
Axsome Therapeutics, Inc.8$151
Otsuka America Pharmaceutical, Inc.12$150
Supernus Pharmaceuticals, Inc.5$89
Vanda Pharmaceuticals Inc.3$59
Teva Pharmaceuticals USA, Inc.3$54

Products named: CAPLYTA, VRAYLAR, Jornay PM, INGREZZA, REXULTI, ARISTADA, Auvelity, Qelbree.

Industry payments across MS — which companies pay providers there.